Embree Financial Group’s Pfizer PFE Stock Holding History

Embree Financial Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$331K	Buy	13,751 +962	+8%	+$25.2K	0.03%	209
2026 Q1	$359K	Buy	12,789 +1,176	+10%	+$31.3K	0.04%	182
2025 Q4	$289K	Sell	11,613 -54	-0.5%	-$1.36K	0.04%	197
2025 Q3	$297K	Sell	11,667 -627	-5%	-$15.5K	0.04%	185
2025 Q2	$298K	Sell	12,294 -230	-2%	-$5.36K	0.04%	174
2025 Q1	$317K	Buy	12,524 +2,826	+29%	+$73.9K	0.05%	157
2024 Q4	$257K	Sell	9,698 -8,489	-47%	-$230K	0.04%	171
2024 Q3	$526K	Buy	18,187 +108	+0.6%	+$3.15K	0.09%	113
2024 Q2	$506K	Sell	18,079 -6,811	-27%	-$188K	0.1%	110
2024 Q1	$691K	Sell	24,890 -6,538	-21%	-$181K	0.14%	93
2023 Q4	$905K	Buy	+31,428	New	+$950K	0.19%	81

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Embree Financial Group's PFE Position: Q2 2026 in Review

Embree Financial Group increased its Pfizer (PFE) stake by 7.5% in Q2 2026, buying an estimated $25.2K and bringing the position to 13,751 shares worth $331K. The position accounts for 0.03% of the portfolio, ranked #209.

Embree Financial Group first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $905K in Q4 2023. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Embree Financial Group held 13,751 shares of Pfizer worth $331K as of Q2 2026.
Embree Financial Group bought 962 Pfizer shares in Q2 2026, an estimated $25.2K.
Pfizer made up 0.03% of Embree Financial Group's portfolio in Q2 2026, its #209 holding.
Embree Financial Group first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
Embree Financial Group's Pfizer position peaked at $905K in Q4 2023.
491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.